CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. PATENT & TECHNOLOGY LICENSE AGREEMENT AGT....Patent & Technology License Agreement • October 24th, 2024 • Regulus Therapeutics Inc. • Pharmaceutical preparations • Texas
Contract Type FiledOctober 24th, 2024 Company Industry JurisdictionThis Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 201 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and Regulus Therapeutics Inc., a Delaware corporation, with its principal place of business at 4224 Campus Point Court, Suite 210, San Diego, CA 92121 (“Licensee”) (collectively, “Parties”, or singly, “Party”).